Exposure to Perfluoroalkyl Substances and Metabolic Outcomes in Pregnant Women: Evidence from the Spanish INMA Birth Cohorts
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background: Exposure to perfluoroalkyl substances (PFASs) may increase risk for metabolic diseases; however, epidemiologic evidence is lacking at the present time. Pregnancy is a period of enhanced tissue plasticity for the fetus and the mother and may be a critical window of PFAS exposure susceptibility. Objective: We evaluated the associations between PFAS exposures and metabolic outcomes in pregnant women. Methods: We analyzed 1,240 pregnant women from the Spanish INMA [Environment and Childhood Project (INfancia y Medio Ambiente)] birth cohort study (recruitment period: 2003–2008) with measured first pregnancy trimester plasma concentrations of four PFASs (in nanograms/milliliter). We used logistic regression models to estimate associations of PFASs (log10-transformed and categorized into quartiles) with impaired glucose tolerance (IGT) and gestational diabetes mellitus (GDM), and we used linear regression models to estimate associations with first-trimester serum levels of triglycerides, total cholesterol, and C-reactive protein (CRP). Results: Perfluorooctane sulfonate (PFOS) and perfluorohexane sulfonate (PFHxS) were positively associated with IGT (137 cases) [OR per log10-unit increase=1.99 (95% CI: 1.06, 3.78) and OR=1.65 ( 95% CI: 0.99, 2.76), respectively]. PFOS and PFHxS associations with GDM (53 cases) were in a similar direction, but less precise. PFOS and perfluorononanoate (PFNA) were negatively associated with triglyceride levels [percent median change per log10-unit increase=−5.86% (95% CI: −9.91%, −1.63%) and percent median change per log10-unit increase=−4.75% (95% CI: −8.16%, −0.61%, respectively], whereas perfluorooctanoate (PFOA) was positively associated with total cholesterol [percent median change per log10-unit increase=1.26% (95% CI: 0.01%, 2.54%)]. PFASs were not associated with CRP in the subset of the population with available data (n=640). Conclusions: Although further confirmation is required, the findings from this study suggest that PFAS exposures during pregnancy may influence lipid metabolism and glucose tolerance and thus may impact the health of the mother and her child. https://doi.org/10.1289/EHP1062
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Lau, C., Anitole, K., Hodes, C., Lai, D., Pfahles-Hutchens, A., & Seed, J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm128 · Cited by 2,620
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049
A review on endocrine disruptors and their possible impacts on human health
Kabir, E. R., Rahman, M. S., & Rahman, I. (2015) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2015.06.009 · Cited by 945 · cited 2×
“…associated with short- and long-term adverse outcomes in the mother and in her offspring, including an increased risk of fetal macrosomia (i.e., high birth weight) and hyperinsulinemia, as well as with higher risks of cesarean section and hypertensive disorders in the mother (Kampmann et al. 2015).”
BackgroundEndocrine Disruptors: From Endocrine to Metabolic Disruption
Casals-Casas, C., & Desvergne, B. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-012110-142200 · Cited by 902
Wang, Z., Cousins, I. T., Scheringer, M., Buck, R. C., & Hungerbühler, K. (2014) · Environment International · doi:10.1016/j.envint.2014.04.013 · Cited by 735
Halldorsson, T. I., Rytter, D., Haug, L. S., Bech, B. H., Danielsen, I., Becher, G., Henriksen, T. B., & Olsen, S. F. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104034 · Cited by 353
Hines, E. P., White, S. S., Stanko, J. P., Gibbs-Flournoy, E. A., Lau, C., & Fenton, S. E. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.02.021 · Cited by 282
Breastfeeding as an exposure pathway for perfluorinated alkylates
Mogensen, U. B., Grandjean, P., Nielsen, F., Weihe, P., & Budtz-Jørgensen, E. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b02237 · Cited by 190
Transfer of perfluoroalkyl substances from mother to fetus in a Spanish birth cohort
Manzano-Salgado, C. B., Casas, M., Lopez-Espinosa, M.-J., Ballester, F., Basterrechea, M., Grimalt, J. O., Jiménez, A.-M., Kraus, T., Schettgen, T., Sunyer, J., et al. (2015) · Environmental Research · doi:10.1016/j.envres.2015.07.020 · Cited by 139 · cited 1×
“PFAS exposure may pass from mother to child through the placenta (Manzano-Salgado et al. 2015) and through breast milk (Mogensen et al. 2015).”
BackgroundSelf-citation
Research works printed but not linked: 30
- 10.3109/10408444.2014.952400 · DOI · Paper page
- 10.1097/EDE.0000000000000247 · DOI
- 10.1016/j.envint.2014.04.010 · DOI · Paper page
- 10.1038/s41598-017-02660-w · DOI · Paper page
- 10.1016/j.envint.2014.04.022 · DOI
- 10.1177/0192623311428473 · DOI · Paper page
- 10.1111/ijpo.12092 · DOI · Paper page
- 10.1016/j.envpol.2015.01.024 · DOI · Paper page
- 10.1093/ije/dyr054 · DOI · Paper page
- 10.1039/b924420d · DOI · Paper page
- 10.4239/wjd.v6.i8.1065 · DOI · Paper page
- 10.1021/es501811k · DOI · Paper page
- 10.1016/j.kjms.2012.05.008 · DOI · Paper page
- 10.1016/j.envint.2016.04.004 · DOI
- 10.1016/j.envint.2013.07.013 · DOI
- 10.3109/03014460.2014.968619 · DOI
- 10.1016/j.bbrc.2016.06.135 · DOI
- 10.1111/1471-0528.13261 · DOI · Paper page
- 10.1021/acs.est.5b02489 · DOI · Paper page
- 10.1016/j.atherosclerosis.2009.11.010 · DOI
- 10.1016/j.envres.2016.01.040 · DOI · Paper page
- 10.1016/j.envres.2015.09.001 · DOI
- 10.1016/j.envint.2013.10.004 · DOI · Paper page
- 10.1016/j.envint.2015.11.016 · DOI
- 10.1289/ehp.1205502 · DOI · Paper page
- 10.1016/j.envint.2017.07.016 · DOI · Paper page
- 10.1289/ehp.1408837 · DOI · Paper page
- 10.1186/1475-2891-12-26 · DOI · Paper page
- 10.1016/j.ccl.2015.01.002 · DOI
- 10.1016/j.reprotox.2011.09.009 · DOI · Paper page
Cited by
Sunderland, E. M., Hu, X. C., Dassuncao, C., Tokranov, A. K., Wagner, C. C., & Allen, J. G. (2019) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-018-0094-1 · Cited by 2,786
Endocrine-disrupting chemicals: Implications for human health
Kahn, L. G., Philippat, C., Nakayama, S. F., Slama, R., & Trasande, L. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30129-7 · Cited by 797
Blake, B. E., & Fenton, S. E. (2020) · Toxicology · doi:10.1016/j.tox.2020.152565 · Cited by 499
Gao, K., Zhuang, T., Liu, X., Fu, J., Zhang, J., Fu, J., Wang, L., Zhang, A., Liang, Y., Song, M., et al. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b00715 · Cited by 231
Meneguzzi, A., Fava, C., Castelli, M., & Minuz, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.706352 · Cited by 174
Yu, G., Jin, M., Huang, Y., Aimuzi, R., Zheng, T., Nian, M., Tian, Y., Wang, W., Luo, Z., Shen, L., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106621 · Cited by 141
Yan, D., Jiao, Y., Yan, H., Liu, T., Yan, H., & Yuan, J. (2022) · Environmental Health · doi:10.1186/s12940-022-00858-8 · Cited by 104
Praegnatio Perturbatio—Impact of Endocrine-Disrupting Chemicals
Padmanabhan, V., Song, W., & Puttabyatappa, M. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa035 · Cited by 103
Zhou, W., Zhao, S., Tong, C., Chen, L., Yu, X., Yuan, T., Aimuzi, R., Luo, F., Tian, Y., & Zhang, J. (2019) · Environment International · doi:10.1016/j.envint.2019.03.075 · Cited by 92
Margolis, R., & Sant, K. E. (2021) · Journal of Xenobiotics · doi:10.3390/jox11030008 · Cited by 59
“65, respectively, though both PFOS and PFHxS had a non-significant positive association with GDM [53].”
BackgroundZang, L., Liu, X., Xie, X., Zhou, X., Pan, Y., & Dai, J. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121504 · Cited by 42
Zhang, L., Liang, J., & Gao, A. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.137748 · Cited by 41
Endocrine-disrupting chemicals exposure: Cardiometabolic health risk in humans
Ma, C.-X., Ma, X.-N., Li, H.-L., Mauricio, D., & Fu, S.-B. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02938-8 · Cited by 19
Feng, Y., Wu, H., Feng, L., Zhang, R., Feng, X., Wang, W., Xu, H., & Fu, F. (2024) · Science of The Total Environment · doi:10.1016/j.scitotenv.2024.170130 · Cited by 19
Zhang, Y., Zhang, M., Jiang, S., Hu, H., Wang, X., Yu, F., Huang, Y., & Liang, Y. (2024) · Cancer Causes & Control · doi:10.1007/s10552-024-01865-5 · Cited by 5
“Population-based cohort studies have confirmed that exposure to PFAS in the first trimester may cause abnormal glucose and lipid metabolism, which may affect the health of mother and fetus [57].”
Metadata
- Authors
- Matilla-Santander, N., Valvi, D., Lopez-Espinosa, M.-J., Manzano-Salgado, C. B., Ballester, F., Ibarluzea, J., Santa-Marina, L., Schettgen, T., Guxens, M., Sunyer, J., & Vrijheid, M.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-11
- Volume
- 125
- Issue
- 11
- Pages
- 117004-117004
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2770741917
- Cited by
- 156
- References
- 12
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.